CureDM
Wilmington
About CureDM
CureDM is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.6M
- Funding stage: M&A
- Last round: Series Unknown (Aug 2009)
- Website: curedm.com
- Phone: 610-645-6796
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/curedm-2420430 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.